The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PCSK9 is a sterol-regulated gene mainly expressed in liver and to a lesser extent in kidney and intestine.
“PCSK9 is a sterol-regulated gene mainly expressed in liver and to a lesser extent in kidney and intestine”
From GRP94 Regulates Circulating Cholesterol Levels through Blockade of PCSK9-Induced LDLR Degradation (2015) · cites this paper as Maxwell et al., 2003
The passage labeled Abstract reports that mouse Pcsk9 expression was strongly downregulated by dietary cholesterol and upregulated in SREBP transgenic mice, supporting sterol regulation in liver. The paper’s liver measurements do not establish that PCSK9 is expressed mainly in liver or at lower levels in kidney and intestine; searches for tissue expression and those organs found no supporting passage. No page number is available in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
Flagged first, then by citations
Research works printed but not linked: 43
- Edwards, 1999, Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway, Annu. Rev. Biochem., 68, 157, 10.1146/annurev.biochem.68.1.157 · DOI
- Russell, 1999, Nuclear orphan receptors control cholesterol catabolism, Cell., 97, 539, 10.1016/S0092-8674(00)80763-1 · DOI
- Repa, 2000, The role of orphan nuclear receptors in the regulation of cholesterol homeostasis, Annu. Rev. Cell Dev. Biol., 16, 459, 10.1146/annurev.cellbio.16.1.459 · DOI
- Brown, 1999, A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood, Proc. Natl. Acad. Sci. USA., 96, 11041, 10.1073/pnas.96.20.11041 · DOI · Paper page
- Edwards, 2000, Regulation of gene expression by SREBP and SCAP, Biochim. Biophys. Acta., 1529, 103, 10.1016/S1388-1981(00)00140-2 · DOI
- Yang, 2002, Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER, Cell., 110, 489, 10.1016/S0092-8674(02)00872-3 · DOI · Paper page
- Korn, 1998, Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N), J. Clin. Invest., 102, 2050, 10.1172/JCI5341 · DOI · Paper page
- Shimano, 1996, Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a, J. Clin. Invest., 98, 1575, 10.1172/JCI118951 · DOI
- Shimano, 1997, Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells, J. Clin. Invest., 99, 846, 10.1172/JCI119248 · DOI · Paper page
- Horton, 1998, Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2, J. Clin. Invest., 101, 2331, 10.1172/JCI2961 · DOI
- Sato, 2000, Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins, J. Biol. Chem., 275, 12497, 10.1074/jbc.275.17.12497 · DOI
- Peet, 1998, Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRalpha, Cell., 93, 693, 10.1016/S0092-8674(00)81432-4 · DOI
- Repa, 2002, The liver X receptor gene team: potential new players in atherosclerosis, Nat. Med., 8, 1243, 10.1038/nm1102-1243 · DOI
- Lichtman, 1999, Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate, Arterioscler. Thromb. Vasc. Biol., 19, 1938, 10.1161/01.ATV.19.8.1938 · DOI
- Sehayek, 1998, Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption, Proc. Natl. Acad. Sci. USA., 95, 10194, 10.1073/pnas.95.17.10194 · DOI
- Pavlidis, 2001, Analysis of strain and regional variation in gene expression in mouse brain, Genome Biol., 2, 10.1186/gb-2001-2-10-research0042 · DOI
- Soccio, 2002, The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6, Proc. Natl. Acad. Sci. USA., 99, 6943, 10.1073/pnas.052143799 · DOI · Paper page
- Wang, 1994, SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis, Cell., 77, 53, 10.1016/0092-8674(94)90234-8 · DOI
- Sakakura, 2001, Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis, Biochem. Biophys. Res. Commun., 286, 176, 10.1006/bbrc.2001.5375 · DOI
- Tansey, 2000, Structure and regulation of mammalian squalene synthase, Biochim. Biophys. Acta., 1529, 49, 10.1016/S1388-1981(00)00137-2 · DOI
- Jackson, 1996, Role for sterol regulatory element binding protein in the regulation of farnesyl diphosphate synthase and in the control of cellular levels of cholesterol and triglyceride: evidence from sterol regulation-defective cells, J. Lipid Res., 37, 1712, 10.1016/S0022-2275(20)39114-8 · DOI
- Luong, 2000, Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins, J. Biol. Chem., 275, 26458, 10.1074/jbc.M004160200 · DOI
- Shimomura, 1998, Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver, J. Biol. Chem., 273, 35299, 10.1074/jbc.273.52.35299 · DOI · Paper page
- Swinnen, 1998, Identification of diazepam-binding Inhibitor/Acyl-CoA-binding protein as a sterol regulatory element-binding protein-responsive gene, J. Biol. Chem., 273, 19938, 10.1074/jbc.273.32.19938 · DOI
- Matsuzaka, 2002, Dual regulation of mouse Delta(5)- and Delta(6)-desaturase gene expression by SREBP-1 and PPARalpha, J. Lipid Res., 43, 107, 10.1016/S0022-2275(20)30193-0 · DOI
- Kast, 2001, CTP:phosphocholine cytidylyltransferase, a new sterol- and SREBP-responsive gene, J. Lipid Res., 42, 1266, 10.1016/S0022-2275(20)31577-7 · DOI
- Repa, 2002, Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta, J. Biol. Chem., 277, 18793, 10.1074/jbc.M109927200 · DOI
- Costet, 2000, Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor, J. Biol. Chem., 275, 28240, 10.1074/jbc.M003337200 · DOI
- Repa, 2000, Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers, Science., 289, 1524, 10.1126/science.289.5484.1524 · DOI
- Wellington, 2002, ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation, Lab. Invest., 82, 273, 10.1038/labinvest.3780421 · DOI
- Kane, 1996, Expression, purification, and ligand-binding analysis of recombinant keratinocyte lipid-binding protein (MAL-1), an intracellular lipid-binding found overexpressed in neoplastic skin cells, Biochemistry., 35, 2894, 10.1021/bi952476e · DOI
- Chen, 1997, Characterization of a novel mammalian RGS protein that binds to Galpha proteins and inhibits pheromone signaling in yeast, J. Biol. Chem., 272, 8679, 10.1074/jbc.272.13.8679 · DOI
- Verploegen, 2000, Identification and characterization of CKLiK, a novel granulocyte Ca(++)/calmodulin-dependent kinase, Blood., 96, 3215, 10.1182/blood.V96.9.3215 · DOI
- Seidah, 1999, Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides, Brain Res., 848, 45, 10.1016/S0006-8993(99)01909-5 · DOI
- Gebe, 2000, Molecular cloning, genomic organization and cell-binding characteristics of mouse Spalpha, Immunology., 99, 78, 10.1046/j.1365-2567.2000.00903.x · DOI
- Sagane, 1999, Cloning and chromosomal mapping of mouse ADAM11, ADAM22 and ADAM23, Gene., 236, 79, 10.1016/S0378-1119(99)00253-X · DOI
- Schultz, 2000, Role of LXRs in control of lipogenesis, Genes Dev., 14, 2831, 10.1101/gad.850400 · DOI · Paper page
- Repa, 2000, Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta, Genes Dev., 14, 2819, 10.1101/gad.844900 · DOI
- Cao, 2002, Phospholipid transfer protein is regulated by liver X receptors in vivo, J. Biol. Chem., 277, 39561, 10.1074/jbc.M207187200 · DOI
- Rudling, 1992, Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo, J. Lipid Res., 33, 493, 10.1016/S0022-2275(20)41615-3 · DOI
- Hertzel, 2000, The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function, Trends Endocrinol. Metab., 11, 175, 10.1016/S1043-2760(00)00257-5 · DOI
- Abifadel, 2003, Mutations in PCSK9 cause autosomal dominant hypercholesterolemia, Nat. Genet., 34, 154, 10.1038/ng1161 · DOI · Paper page
- Primakoff, 2000, The ADAM gene family: surface proteins with adhesion and protease activity, Trends Genet., 16, 83, 10.1016/S0168-9525(99)01926-5 · DOI
Cited by
Sorted by citations
Translating molecular discoveries into new therapies for atherosclerosis
Rader, D. J., & Daugherty, A. (2008) · Nature · doi:10.1038/nature06796 · Cited by 515
A Spectrum of PCSK9 Alleles Contributes to Plasma Levels of Low-Density Lipoprotein Cholesterol
Kotowski, I. K., Pertsemlidis, A., Luke, A., Cooper, R. S., Vega, G. L., Cohen, J. C., & Hobbs, H. H. (2006) · The American Journal of Human Genetics · doi:10.1086/500615 · Cited by 517
Bjermo, H., Iggman, D., Kullberg, J., Dahlman, I., Johansson, L., Persson, L., Berglund, J., Pulkki, K., Basu, S., Uusitupa, M., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.030114 · Cited by 490
Lowering LDL—not only how low, but how long?
Brown, M. S., & Goldstein, J. L. (2006) · Science · doi:10.1126/science.1125884 · Cited by 204
Kosenko, T., Golder, M., Leblond, G., Weng, W., & Lagace, T. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421370 · Cited by 181
Targeting PCSK9 for hypercholesterolemia
Norata, G. D., Tibolla, G., & Catapano, A. L. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140025 · Cited by 127
Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins
Soccio, R. E., Adams, R. M., Maxwell, K. N., & Breslow, J. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501778200 · Cited by 118
Self-citationWouters, K., van Bilsen, M., van Gorp, P. J., Bieghs, V., Lütjohann, D., Kerksiek, A., Staels, B., Hofker, M. H., & Shiri-Sverdlov, R. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.046 · Cited by 109
Lalanne, F., Lambert, G., Amar, M. J. A., Chétiveaux, M., Zaïr, Y., Jarnoux, A.-L., Ouguerram, K., Friburg, J., Seidah, N. G., Brewer, H. B., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400396-jlr200 · Cited by 104
GRP94 Regulates Circulating Cholesterol Levels through Blockade of PCSK9-Induced LDLR Degradation
Poirier, S., Mamarbachi, M., Chen, W.-T., Lee, A. S., & Mayer, G. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.006 · Cited by 86
PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum
Strøm, T. B., Tveten, K., & Leren, T. P. (2014) · Biochemical Journal · doi:10.1042/bj20130930 · Cited by 48
Singh, A. B., Li, H., Kan, C. F. K., Dong, B., Nicolls, M. R., & Liu, J. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.301131 · Cited by 32
Metadata
- Authors
- Maxwell, K. N., Soccio, R. E., Duncan, E. M., Sehayek, E., & Breslow, J. L.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 44
- Issue
- 11
- Pages
- 2109-2119
- ISSN
- 0022-2275
- Cited by
- 329
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review